Business
Imagion (ASX:IBX) share price up 1,166% in a year pursuing ‘radiation-free’ cancer tech
The Imagion Biosystems Ltd (ASX: IBX) share price has rocketed 1,166% over the past 12 months due to a series of promising projects around cancer detection.
The company’s bio is truly a mouthful: its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics, and – the clincher — superparamagnetic relaxometry.
What investors should know is that it develops medical devices focused around cancer screening technology.
Imagion’s Magsense cancer screening technology
One of these tech projects, called Magsense, is a diagnostic imaging tool that can potentially increase…
-
Noosa News22 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
Noosa News22 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
Noosa News24 hours agoHelicopter scrambles to site of air crash on K’gari
-
Noosa News19 hours agoGyrocopter pilot injured in crash-landing on K’Gari, north of Brisbane